SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-029322
Filing Date
2017-12-20
Accepted
2017-12-20 16:18:37
Documents
1
Period of Report
2017-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6583
  Complete submission text file 0000899243-17-029322.txt   7976
Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
SCHAEFFER LEONARD D (Reporting) CIK: 0001016369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38293 | Film No.: 171266945

Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01830 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations